Mark L. Kuijf

2.9k total citations · 1 hit paper
64 papers, 1.9k citations indexed

About

Mark L. Kuijf is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Mark L. Kuijf has authored 64 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Neurology, 17 papers in Cellular and Molecular Neuroscience and 12 papers in Cognitive Neuroscience. Recurrent topics in Mark L. Kuijf's work include Parkinson's Disease Mechanisms and Treatments (35 papers), Neurological disorders and treatments (32 papers) and Peripheral Neuropathies and Disorders (10 papers). Mark L. Kuijf is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (35 papers), Neurological disorders and treatments (32 papers) and Peripheral Neuropathies and Disorders (10 papers). Mark L. Kuijf collaborates with scholars based in Netherlands, United States and France. Mark L. Kuijf's co-authors include Albert F.G. Leentjens, Martijn Broen, N. Dissanayaka, Yasin Temel, Bart C. Jacobs, Pieter Kubben, Annelien Duits, Jeroen Habets, C. Wim Ang and Sjors C.F. van de Weijer and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Neurology.

In The Last Decade

Mark L. Kuijf

57 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of anxiety in Parkinson's disease: A systematic review and meta‐analysis

2016 286 citations Mark L. Kuijf, Albert F.G. Leentjens et al. profile →

Peers

Countries citing papers authored by Mark L. Kuijf

Since Specialization

Citations

This map shows the geographic impact of Mark L. Kuijf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Kuijf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Kuijf more than expected).

Fields of papers citing papers by Mark L. Kuijf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Kuijf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Kuijf. The network helps show where Mark L. Kuijf may publish in the future.

Co-authorship network of co-authors of Mark L. Kuijf

This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. Kuijf. A scholar is included among the top collaborators of Mark L. Kuijf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. Kuijf. Mark L. Kuijf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cortical thickness alterations in Parkinson's disease related anxiety: A cross-sectional 7 T MRI study 2025 ·Journal of Parkinson s Disease ·(unknown), (unknown), Romain Viard, Mark L. Kuijf, (unknown), Kathy Dujardin, Albert F.G. Leentjens	0
2	Reduced volume of the mediodorsal and anteroventral thalamus is associated with anxiety in Parkinson's disease: A cross-sectional 7-tesla MRI study 2025 ·Journal of Parkinson s Disease ·(unknown), Mark L. Kuijf, Stijn Michielse, (unknown), Kathy Dujardin, Albert F.G. Leentjens	0
3	Prevalence of Parkinson's Disease in 22q11.2 Deletion Syndrome: A Multicenter Study 2025 ·Movement Disorders Clinical Practice ·(unknown), Ann Swillen, Gabriela M. Repetto, (unknown), Anthony E. Lang, Connie Marras, Mark L. Kuijf, Rob P.W. Rouhl, Agnies M. van Eeghen, Carlos Juri, Annick Vogels, Thérèse van Amelsvoort, Anne S. Bassett, Erik Boot	0
4	Deep Brain Stimulation for Dystonia in the Netherlands: A Delphi Study to Develop National Consensus 2025 ·Tremor and Other Hyperkinetic Movements ·(unknown), Linda Ackermans, Annemieke I. Buizer, Maria Fiorella Contarino, Joke M. Dijk, Annelien Duits, C.F.E. Hoffmann, Mark L. Kuijf, (unknown), D. L. Marinus Oterdoom, Laura A. van de Pol, Rick Schuurman, Marina A.J. Tijssen, Martje E. van Egmond	0
5	Deep brain stimulation in a patient with dystonic tremor with a novel familial VPS16 gene mutation 2024 ·(unknown), Pieter Kubben, Linda Ackermans, Mayke Oosterloo, Mark L. Kuijf, Marcus L.F. Janssen	0
6	Deep brain stimulation of the subthalamic nucleus in Parkinson’s disease after 15 years: Clinical outcome and caregiver burden 2023 ·(unknown), (unknown), Annelien Duits, Linda Ackermans, (unknown), Mark L. Kuijf, Yasin Temel	1
7	Impact of preoperative computed tomography image slice thickness on the planning of deep brain stimulation surgery: A phantom study 2023 ·(unknown), (unknown), Linda Ackermans, Pieter Kubben, Mark L. Kuijf, Ersoy Kocabıçak, Yasin Temel	0
8	Brain network characteristics and cognitive performance in motor subtypes of Parkinson's disease: A resting state fMRI study 2022 ·Parkinsonism & Related Disorders ·(unknown), Stijn Michielse, Mark L. Kuijf, Luc Defebvre, Renaud Lopes, Kathy Dujardin, Albert F.G. Leentjens	6
9	Parkinsonism in Genetic Neurodevelopmental Disorders: A Systematic Review 2022 ·Movement Disorders Clinical Practice ·(unknown), Agnies M. van Eeghen, Tom J. de Koning, Mark L. Kuijf, Janneke Zinkstok, (unknown), Thérèse van Amelsvoort, Erik Boot	6
10	Cognitive Behavioral Therapy for Anxiety in Parkinson’s Disease Induces Functional Brain Changes 2022 ·Journal of Parkinson s Disease ·(unknown), Renaud Lopes, Anja J.H. Moonen, (unknown), J. de Jong, Grégory Kuchcinski, Luc Defebvre, Mark L. Kuijf, Kathy Dujardin, Albert F.G. Leentjens	15
11	Comparison of Olfactory Tract Diffusion Measures Between Early Stage Parkinson’s Disease Patients and Healthy Controls Using Ultra-High Field MRI 2022 ·Journal of Parkinson s Disease ·(unknown), (unknown), Yasin Temel, Mark L. Kuijf, Stijn Michielse	3
12	Surgical and Hardware-Related Adverse Events of Deep Brain Stimulation: A Ten-Year Single-Center Experience 2022 ·Neuromodulation Technology at the Neural Interface ·(unknown), (unknown), Linda Ackermans, Albert F.G. Leentjens, Marcus L.F. Janssen, Mark L. Kuijf, Koen Schruers, Annelien Duits, (unknown), Pieter Kubben, Yasin Temel	11
13	A Long-Term, Real-Life Parkinson Monitoring Database Combining Unscripted Objective and Subjective Recordings 2021 ·Data ·Jeroen Habets, (unknown), Albert F.G. Leentjens, Claudia J.P. Simons, Yasin Temel, Mark L. Kuijf, Pieter Kubben, Christian Herff	6
14	Variability in subthalamic nucleus targeting for deep brain stimulation with 3 and 7 Tesla magnetic resonance imaging 2021 ·NeuroImage Clinical ·(unknown), Monique Heijmans, Mark L. Kuijf, Pieter Kubben, Linda Ackermans, Yasin Temel, Max C. Keuken, Birte U. Forstmann	11
15	The TRACK-PD study: protocol of a longitudinal ultra-high field imaging study in Parkinson’s disease 2020 ·BMC Neurology ·(unknown), (unknown), Stijn Michielse, Albert F.G. Leentjens, Alida A. Postma, (unknown), Dimo Ivanov, Annelien Duits, Yasin Temel, Mark L. Kuijf	13
16	Mobile Health Daily Life Monitoring for Parkinson Disease: Development and Validation of Ecological Momentary Assessments 2019 ·JMIR mhealth and uhealth ·Jeroen Habets, (unknown), Christian Herff, Claudia J.P. Simons, Albert F.G. Leentjens, Yasin Temel, Mark L. Kuijf, Pieter Kubben	17
17	Selecting candidates for Deep Brain Stimulation in Parkinson's disease: the role of patients' expectations 2019 ·Parkinsonism & Related Disorders ·Victor J. Geraedts, Mark L. Kuijf, Jacobus J. van Hilten, Johan Marinus, Mayke Oosterloo, Maria Fiorella Contarino	20
18	Resting-state fMRI in Parkinson's disease patients with cognitive impairment: A meta-analysis 2018 ·Parkinsonism & Related Disorders ·(unknown), Sjors C.F. van de Weijer, Albert F.G. Leentjens, Annelien Duits, Heidi I.L. Jacobs, Mark L. Kuijf	136
19	Is there still need for microelectrode recording now the subthalamic nucleus can be well visualized with high field and ultrahigh MR imaging? 2015 ·Frontiers in Integrative Neuroscience ·Ersoy Kocabıçak, (unknown), Linda Ackermans, Pieter Kubben, Mark L. Kuijf, Erkan Kurt, Rianne A.J. Esselink, Yasin Temel	18
20	Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain–Barré syndrome and Miller Fisher syndrome 2012 ·Clinical Microbiology and Infection ·Astrid P. Heikema, Bart C. Jacobs, Deborah Horst-Kreft, Ruth Huizinga, Mark L. Kuijf, Hubert P. Endtz, Janneke N. Samsom, Willem J. B. van Wamel	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact